Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Stacy S, Shord"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 11, Pp 1573-1576 (2023)
Externí odkaz:
https://doaj.org/article/3403c3b027e44653962206bc7f1dfc91
Autor:
Sriram Subramaniam, Stacy S. Shord, Ruby Leong, Kelly Norsworthy, Atiqur Rahman, Brian Booth, Olanrewaju Okusanya
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 5, Pp 719-722 (2023)
Externí odkaz:
https://doaj.org/article/2a874c895da64594bfffa79fa9b59a2c
Autor:
Richard Pazdur, Gideon M. Blumenthal, Ann T. Farrell, Kirsten B. Goldberg, Jiang Liu, Anamitro Banerjee, Christopher M. Sheth, Stacy S. Shord, Yuan Li Shen, Donna Przepiorka, David A. Bateman, Gerlie Gieser, Kumar G. Janoria, Wentao Fu, Paresma Patel, Michael L. Manning, Liang Li, Xin Gao, Aviva C. Krauss
On August 3, 2017, the FDA granted regular approval to Vyxeos (also known as CPX-351; Jazz Pharmaceuticals), a liposomal formulation of daunorubicin and cytarabine in a fixed combination, for the treatment of adults with newly diagnosed therapy-relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54674ded12a4d242af56ef0583b02f7c
https://doi.org/10.1158/1078-0432.c.6528362
https://doi.org/10.1158/1078-0432.c.6528362
Autor:
Richard Pazdur, Gideon M. Blumenthal, Ann T. Farrell, Kirsten B. Goldberg, Jiang Liu, Anamitro Banerjee, Christopher M. Sheth, Stacy S. Shord, Yuan Li Shen, Donna Przepiorka, David A. Bateman, Gerlie Gieser, Kumar G. Janoria, Wentao Fu, Paresma Patel, Michael L. Manning, Liang Li, Xin Gao, Aviva C. Krauss
Supplemental Table S1: Grouped Terms for Adverse Reactions on Study 301
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4c8d39e6c98e8ee1b0d9194c689465
https://doi.org/10.1158/1078-0432.22472897.v1
https://doi.org/10.1158/1078-0432.22472897.v1
Autor:
Yuching Yang, Sriram Subramaniam, Donna Przepiorka, Lei Nie, Amy E. McKee, Richard Pazdur, Lian Ma, Stacy S. Shord, Ann T. Farrell, Chia-Wen Ko, Yvette L. Kasamon
Publikováno v:
The Oncologist
In April 2017, the U.S. Food and Drug Administration (FDA) granted regular approval to midostaurin for the treatment of adult patients with aggressive systemic mastocytosis, systemic mastocytosis with associated hematological neoplasm, and mast cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db41fbcfb9ee211dc171ac26d33f7d41
https://doi.org/10.1634/theoncologist.2018-0222
https://doi.org/10.1634/theoncologist.2018-0222
Autor:
Lola Luo, Yuan Li Shen, Kirsten B. Goldberg, Sriram Subramaniam, Amy E. McKee, Ann T. Farrell, Virginia E. Kwitkowski, Edvardas Kaminskas, Stacy S. Shord, Patricia A. Oneal, Richard Pazdur
Publikováno v:
The Oncologist
The FDA has granted regular approval to vemurafenib for the treatment of adult patients with Erdheim‐Chester Disease (ECD) with BRAFV600 mutation. This article describes the FDA review of the evidence and the clinical implications for this rare pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75f5774426c8f43957529fd5231d1144
http://europepmc.org/articles/PMC6292556
http://europepmc.org/articles/PMC6292556
Autor:
Stacy S. Shord
Publikováno v:
The Journal of Clinical Pharmacology. 57:S99-S104
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e538ec45745b245dbbfe5b12be28c98b
https://doi.org/10.1002/jcph.922
https://doi.org/10.1002/jcph.922
Autor:
Lola Luo, Sriram Subramaniam, Nicole J. Gormley, Guoxiang Shen, Lian Ma, Rajeshwari Sridhara, Yuan Li Shen, Richard Pazdur, Stacy S. Shord, Kirsten B. Goldberg, Ann T. Farrell, Vishal Bhatnagar, Amy E. McKee
Publikováno v:
The Oncologist
Multiple myeloma is mostly an incurable disease. The U.S. Food and Drug Administration (FDA) granted daratumumab accelerated approval in November 2015 as monotherapy for patients with multiple myeloma who have received at least three prior lines of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ffa71ccd830468865dd47cc819713c
https://doi.org/10.1634/theoncologist.2017-0229
https://doi.org/10.1634/theoncologist.2017-0229
Autor:
Patricia Keegan, Hong Zhao, Denise Casey, Alexander H. Putman, Richard Pazdur, Stacy S. Shord, Huanyu Chen, Whitney S. Helms, Kun He, Suzanne Demko
Publikováno v:
Clinical Cancer Research. 23:2377-2381
On July 24, 2015, the FDA approved sonidegib (ODOMZO; Novartis) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) not amenable to curative surgery or radiotherapy. The approval was based on data from one randomized, dou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f27663644de348827de87e9b9a0abdbd
https://doi.org/10.1158/1078-0432.ccr-16-2051
https://doi.org/10.1158/1078-0432.ccr-16-2051
Autor:
Stacy S Shord
Publikováno v:
Novel Methods in Bioanalysis and Characterization of Antibody-Drug Conjugates. :90-99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97cced1d2b58e9ee205c61719c55eb5a
https://doi.org/10.4155/fseb2013.14.152
https://doi.org/10.4155/fseb2013.14.152